Skip to main content
. 2017 Oct 31;4:17. doi: 10.1186/s40661-017-0052-y

Fig. 2.

Fig. 2

Therapeutic targets in ARID1A mutated cancers. Novel targeting of several key regulators in the PI3K/AKT/mTOR pathway and SWI/SNF complex modulate downstream effectors to inhibit cellular proliferation and promote apoptosis (Fig. 2)